Literature DB >> 9180251

Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults.

M Madhavan1, W A Wattigney, S R Srinivasan, G S Berenson.   

Abstract

There is evidence that bilirubin functions as an endogenous tissue protector by its antioxidant and anti-complement actions, properties that are relevant to atherogenesis. Serum bilirubin distribution and its relation to cardiovascular risk were examined in 4156 individuals aged 5-30 years from a biracial (black white) community. Bilirubin levels showed significant differences related to race (whites > blacks) and sex (males > females, except in 5-10 year olds). In males the levels increased with age up to 24 years, while in females the changes were less conspicuous. Both adiposity and cigarette smoking associated independently and inversely with bilirubin. In addition, serum bilirubin correlated positively with HDL cholesterol and inversely with triglycerides, VLDL cholesterol, LDL cholesterol, insulin, glucose and systolic blood pressure although these correlations were significant only in certain age-race-sex groups. Offspring with a parental history of heart attack or hypertension had consistently lower bilirubin levels than those without such parental history. Thus, bilirubin may be an inverse risk factor for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180251     DOI: 10.1016/s0021-9150(97)06088-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Atazanavir improves cardiometabolic measures but not vascular function in patients with long-standing type 1 diabetes mellitus.

Authors:  Jessica Milian; Allison B Goldfine; Jonah P Zuflacht; Caitlin Parmer; Joshua A Beckman
Journal:  Acta Diabetol       Date:  2015-01-08       Impact factor: 4.280

2.  Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease.

Authors:  Stephanie S O'Malley; Ran Wu; Susan T Mayne; Peter I Jatlow
Journal:  Nicotine Tob Res       Date:  2014-05-08       Impact factor: 4.244

Review 3.  Hyperbilirubinemia, Hypertension, and CKD: the Links.

Authors:  Ibrahim Mortada
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

Review 4.  Reactive oxygen species in cardiovascular disease.

Authors:  Koichi Sugamura; John F Keaney
Journal:  Free Radic Biol Med       Date:  2011-05-15       Impact factor: 7.376

Review 5.  Metabolic syndrome and coronary artery disease in adults with congenital heart disease.

Authors:  Koichiro Niwa
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

6.  Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.

Authors:  Satoshi Yoshino; Shuichi Hamasaki; Sanemasa Ishida; Tetsuro Kataoka; Akiko Yoshikawa; Naoya Oketani; Keishi Saihara; Hitoshi Ichiki; So Kuwahata; Shoji Fujita; Takuro Takumi; Issei Yoshimoto; Mitsuhiro Nakazaki; Chuwa Tei
Journal:  Heart Vessels       Date:  2012-03-29       Impact factor: 2.037

7.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

8.  Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study.

Authors:  Atsunori Nakao; Yoshiya Toyoda; Prachi Sharma; Malkanthi Evans; Najla Guthrie
Journal:  J Clin Biochem Nutr       Date:  2010-02-24       Impact factor: 3.114

9.  Relationship between serum bilirubin concentration and nondipper hypertension.

Authors:  Mehmet Demir; Canan Demir; Serdar Keçeoğlu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

10.  Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Authors:  E Beutler; T Gelbart; A Demina
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.